Scientists in China have performed an experiment first proposed by Albert Einstein almost a century ago when he sought to ...

ROCKVILLE, Md. and SUZHOU, China, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage ...

Good day, and thank you for standing by. Welcome to the ORIC Enozertinib Program Update Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would ...

Wall Street was sorting through two batches of news from Jasper Therapeutics Inc., which made public positive data from the phase Ib study called Etesian with KIT-targeting briquilimab in adults with ...

Good day, and welcome to the TX45 Phase Ib Part B PH-HFrEF data conference call. [Operator Instructions] As a reminder, this call may be recorded. I would now like to turn the call over to Dr. Alise ...

DeLLphi-303 Phase Ib trial results demonstrate acceptable safety profile, unprecedented survival in ES-SCLC by International Association for the Study of Lung Cancer edited by Sadie Harley, reviewed ...

Nobody does pasta quite like the Italians, as anyone who has tasted an authentic “pasta alla cacio e pepe” can attest. It’s a simple dish: just tonnarelli pasta, pecorino cheese, and pepper. But its ...

(RTTNews) - Ascletis Pharma Inc. (ASCLF.PK) announced positive topline results from its randomized, double-blind, placebo-controlled Phase Ib multiple ascending dose (MAD) study of ASC30 oral ...

- ASC30 oral once-daily tablet demonstrated a 6.5% placebo-adjusted mean body weight reduction from baseline after four-week treatment using weekly doses with titrations of 2 mg, 10 mg, 20 mg, and 40 ...